Juno Therapeutics (JUNO) Announces Prelim. JCAR017 Data in r/r NHL; No sCRS Observed
Tweet Send to a Friend
Juno Therapeutics, Inc. (Nasdaq: JUNO) announced encouraging preliminary clinical data for JCAR017 in patients with relapsed or refractory (r/r) aggressive ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE